Page 1 of Clinical Trials for MorphoSys AG [SPONSOR-COLLABORATORS], 3 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
A Study of the Safety and Preliminary Efficacy of MOR103, a Human Antibody to Granulocyte Macrophage Colony-stimulating Factor (GM-CSF), in Patients With Active Rheumatoid Arthritis
Last Updated: March 6, 2012
Condition(s): Rheumatoid Arthritis
2
Recruiting
Phase Ib Study to Evaluate the Safety and Pharmacokinetics of MOR103, a Human Antibody to GM-CSF, in Patients With Multiple Sclerosis
Last Updated: March 22, 2012
Condition(s): Multiple Sclerosis
3
Recruiting
A Phase I/IIa Study of Human Anti-CD38 Antibody MOR03087 in Relapsed/Refractory Multiple Myeloma
Last Updated: October 26, 2011
Condition(s): Multiple Myeloma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=MorphoSys+AG

Page 1 of Clinical Trials for MorphoSys AG [SPONSOR-COLLABORATORS], 3 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About